<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mice with <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo> (C.B-17 scid, hereafter <z:mp ids='MP_0002536'>SCID</z:mp>) accept xenografts of adult human peripheral blood leukocytes (PBL) </plain></SENT>
<SENT sid="1" pm="."><plain>The transplanted human PBL expand in number and survive for at least thirteen months and have been shown to reconstitute human immune function at both the T and B cell levels </plain></SENT>
<SENT sid="2" pm="."><plain>Human immunoglobulin production is restored, and secondary antibody responses to antigens such as <z:e sem="disease" ids="C0039614" disease_type="Disease or Syndrome" abbrv="">tetanus</z:e> toxoid can be induced </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:mp ids='MP_0002536'>SCID</z:mp> mice reconstituted with 50 x 10(6) or more PBL from donors with evidence of exposure to Epstein-Barr virus (EBV) have developed human B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> at 8-16 weeks after PBL engraftment, whereas mice reconstituted with PBL from EBV-seronegative donors fail to develop <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>These <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> involve both lymphatic and non-lymphatic organs, and histologically they resemble large cell or <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are associated with high levels of human immunoglobulin secretion and serum electrophoresis reveals oligoclonal immunoglobulin banding patterns </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> DNA shows the presence of EBV genomes and oligoclonal patterns of immunoglobulin JH gene rearrangement </plain></SENT>
<SENT sid="7" pm="."><plain>Taken together, these observations suggest an EBV-related proliferation of B lymphocytes leading to the rapid appearance of oligoclonal B cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> following transfer of B lymphocytes from "<z:mpath ids='MPATH_458'>normal</z:mpath>" donors to <z:mp ids='MP_0002536'>SCID</z:mp> mice </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0002536'>SCID</z:mp> mice reconstituted with PBL from EBV-seronegative donors have been infected with the LAV-1 strain of human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV-1) </plain></SENT>
<SENT sid="9" pm="."><plain>Virus has been recovered from most infected animals by co-culture of mouse tissue with human T lymphoblasts </plain></SENT>
<SENT sid="10" pm="."><plain>Some mice with high virus titers have developed an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0005150'>wasting</z:mp> syndrome and <z:mpath ids='MPATH_63'>depletion</z:mpath> of human T cells.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>